Filing Details

Accession Number:
0001209191-14-044386
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-06-30 16:06:38
Reporting Period:
2014-06-26
Filing Date:
2014-06-30
Accepted Time:
2014-06-30 16:06:38
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1488613 Foundation Medicine Inc. FMI Services-Medical Laboratories (8071) 271316416
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1585017 Jason Ryan 150 Second Street
C/O Foundation Medicine, Inc.
Cambridge MA 02141
Senior Vice President, Finance No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-06-26 1,180 $0.08 1,180 No 4 M Direct
Common Stock Disposition 2014-06-26 1,180 $25.00 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2014-06-26 1,180 $0.00 1,180 $0.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
25,627 2021-06-15 No 4 M Direct
Footnotes
  1. The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2013.
  2. The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2013.
  3. This option was granted on June 15, 2011. Twenty-five percent vested on May 16, 2012 and an additional 6.25% vests each successive quarter thereafter until fully vested on May 16, 2015.